Most sold healthcare stocks in Q1 2018
See which Healthcare stocks institutional investors trimmed or exited the most in Q1 2018, measured as net reductions in reported share positions from Q4 2017 into Q1 2018. Notable reductions at the top of this list include PATTERSON COS INC (PDCO), AGILENT TECHNOLOGIES INC (A), DANAHER CORP (DHR), ALNYLAM PHARMACEUTICALS INC (ALNY). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| PDCO | PATTERSON COS INC | -5,162,771 | -$254.00M | 1 | 1 | 2 | 0 | 4 |
| A | AGILENT TECHNOLOGIES INC | -3,802,504 | -$255.13M | 0 | 1 | 1 | 1 | 3 |
| DHR | DANAHER CORP | -3,311,922 | -$215.22M | 0 | 3 | 5 | 1 | 10 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | -3,302,440 | -$458.84M | 0 | 2 | 1 | 0 | 3 |
| COR | CENCORA INC | -2,739,969 | -$286.52M | 0 | 1 | 2 | 0 | 3 |
| JNJ | JOHNSON & JOHNSON | -2,300,071 | -$556.33M | 0 | 7 | 8 | 1 | 18 |
| PFE | PFIZER INC | -2,248,522 | -$94.04M | 0 | 4 | 7 | 4 | 11 |
| BAX | BAXTER INTERNATIONAL INC | -2,110,940 | -$121.11M | 0 | 0 | 4 | 1 | 7 |
| MOH | MOLINA HEALTHCARE INC | -2,068,679 | -$149.18M | 1 | 0 | 1 | 2 | 2 |
| GILD | GILEAD SCIENCES INC | -2,053,093 | $14.03M | 0 | 6 | 2 | 1 | 9 |
| HALO | HALOZYME THERAPEUTICS INC | -1,369,076 | -$30.49M | 0 | 2 | 1 | 0 | 4 |
| AZN | ASTRAZENECA PLC-SPONS ADR | -1,073,700 | -$22.26M | 0 | 1 | 1 | 0 | 2 |
| GERN | GERON CORP | -1,016,815 | -$1.83M | 0 | 0 | 0 | 2 | 0 |
| PRGO | Perrigo Company PLC | -961,512 | -$101.11M | 0 | 0 | 3 | 0 | 3 |
| BSX | BOSTON SCIENTIFIC CORP | -907,445 | -$9.07M | 0 | 1 | 3 | 0 | 4 |
| SNY | SANOFI-ADR | -746,740 | -$224.09M | 0 | 0 | 3 | 1 | 5 |
| NKTR | NEKTAR THERAPEUTICS | -733,548 | $11.68M | 0 | 0 | 1 | 1 | 1 |
| VREX | VAREX IMAGING CORP | -719,743 | -$37.82M | 0 | 0 | 2 | 2 | 2 |
| UHS | UNIVERSAL HEALTH SERVICES-B | -704,355 | -$79.61M | 0 | 0 | 1 | 1 | 1 |
| PHG | KONINKLIJKE PHILIPS NVR- NY | -659,400 | -$24.70M | 0 | 0 | 1 | 0 | 2 |
| IQV | IQVIA HOLDINGS INC | -651,666 | -$61.65M | 0 | 1 | 1 | 1 | 2 |
| PINC | PREMIER INC-CLASS A | -650,595 | -$18.35M | 0 | 1 | 1 | 1 | 2 |
| HSIC | HENRY SCHEIN INC | -612,712 | -$43.04M | 0 | 1 | 0 | 1 | 1 |
| MDXG | MIMEDX GROUP INC | -551,155 | -$10.97M | 0 | 0 | 1 | 1 | 1 |
| DGX | QUEST DIAGNOSTICS INC | -533,090 | -$51.45M | 0 | 0 | 2 | 0 | 2 |
| EW | EDWARDS LIFESCIENCES CORP | -511,758 | $59.38M | 0 | 1 | 3 | 0 | 4 |
| PCRX | PACIRA BIOSCIENCES INC | -509,900 | -$23.28M | 0 | 0 | 0 | 1 | 0 |
| BMY | BRISTOL-MYERS SQUIBB CO | -449,766 | $63.87M | 0 | 6 | 4 | 1 | 10 |
| UNH | UNITEDHEALTH GROUP INC | -387,606 | -$250.16M | 0 | 8 | 8 | 0 | 17 |
| CDXS | CODEXIS INC | -365,700 | -$2.75M | 0 | 0 | 1 | 0 | 1 |
| ABT | ABBOTT LABORATORIES | -285,768 | -$3.68M | 0 | 1 | 3 | 0 | 6 |
| LXRX | LEXICON PHARMACEUTICALS INC | -275,800 | -$3.02M | 0 | 0 | 1 | 0 | 1 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | -250,800 | -$13.24M | 0 | 1 | 1 | 0 | 2 |
| BDX | BECTON DICKINSON AND CO | -245,675 | -$32.50M | 0 | 3 | 7 | 0 | 10 |
| NBIX | NEUROCRINE BIOSCIENCES INC | -224,900 | -$16.58M | 0 | 0 | 1 | 0 | 1 |
| OMI | OWENS & MINOR INC | -221,228 | -$9.09M | 0 | 0 | 1 | 1 | 1 |
| ALGN | ALIGN TECHNOLOGY INC | -182,833 | $150.56M | 1 | 3 | 2 | 1 | 6 |
| TDOC | TELADOC HEALTH INC | -175,907 | -$5.63M | 0 | 1 | 0 | 1 | 1 |
| GLYC | GLYCOMIMETICS INC | -174,500 | -$2.93M | 0 | 0 | 0 | 1 | 0 |
| EDIT | EDITAS MEDICINE INC | -166,734 | $1.30M | 0 | 1 | 1 | 0 | 2 |
| RVTY | REVVITY INC | -166,600 | -$12.18M | 0 | 0 | 0 | 1 | 0 |
| BKD | BROOKDALE SENIOR LIVING INC | -159,218 | -$3.58M | 0 | 0 | 1 | 0 | 1 |
| ABUS | ARBUTUS BIOPHARMA CORP | -159,073 | -$815.00K | 0 | 0 | 1 | 0 | 1 |
| CORT | CORCEPT THERAPEUTICS INC | -156,000 | -$10.54M | 0 | 0 | 1 | 0 | 1 |
| WAT | WATERS CORP | -149,301 | $11.53M | 1 | 2 | 2 | 0 | 5 |
| FGEN | FIBROGEN INC | -141,700 | -$6.92M | 0 | 0 | 1 | 0 | 1 |
| COLL | COLLEGIUM PHARMACEUTICAL INC | -117,300 | -$2.07M | 0 | 0 | 1 | 0 | 1 |
| IART | INTEGRA LIFESCIENCES HOLDING | -115,300 | -$3.35M | 0 | 0 | 1 | 0 | 1 |
| SNN | SMITH & NEPHEW PLC -SPON ADR | -113,450 | -$3.28M | 0 | 0 | 1 | 0 | 1 |
| FATE | FATE THERAPEUTICS INC | -105,100 | -$496.00K | 0 | 0 | 1 | 0 | 1 |
Frequently asked questions about Most sold healthcare stocks in Q1 2018
What are the most sold Healthcare stocks in Q1 2018?
The most sold healthcare stocks in Q1 2018 are those with the largest decrease in reported share counts across institutional investors compared to Q4 2017, based on SEC 13F filings.
Which healthcare stocks did institutional investors trimmed or exited the most in Q1 2018?
Among filers in this sector, net reductions were largest in companies such as PATTERSON COS INC (PDCO), AGILENT TECHNOLOGIES INC (A), DANAHER CORP (DHR), based on aggregated 13F data.
How is institutional selling calculated?
Selling is calculated by summing the net decrease in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q4 2017).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.